Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hemorrhagic Fever, Ebola | 5 | 2021 | 1475 | 0.84 | Why? |
| Family Characteristics | 2 | 2021 | 2551 | 0.43 | Why? |
| Epidemics | 4 | 2018 | 6407 | 0.40 | Why? |
| Trypanosomiasis, African | 2 | 2018 | 31 | 0.33 | Why? |
| Schools | 2 | 2021 | 4187 | 0.30 | Why? |
| Measles | 3 | 2019 | 608 | 0.30 | Why? |
| Models, Statistical | 6 | 2021 | 5312 | 0.26 | Why? |
| Models, Theoretical | 9 | 2021 | 6659 | 0.26 | Why? |
| Slovakia | 1 | 2021 | 135 | 0.22 | Why? |
| England | 3 | 2021 | 5116 | 0.21 | Why? |
| Trypanosoma brucei gambiense | 2 | 2018 | 23 | 0.20 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.18 | Why? |
| Liberia | 1 | 2017 | 108 | 0.17 | Why? |
| Feasibility Studies | 3 | 2020 | 3467 | 0.16 | Why? |
| Ebola Vaccines | 1 | 2016 | 126 | 0.15 | Why? |
| Bias | 1 | 2021 | 1109 | 0.15 | Why? |
| Immunity, Herd | 2 | 2020 | 1011 | 0.15 | Why? |
| Disease Outbreaks | 7 | 2021 | 27595 | 0.15 | Why? |
| Monkeypox | 1 | 2014 | 40 | 0.14 | Why? |
| Disease Eradication | 2 | 2020 | 581 | 0.14 | Why? |
| Time | 1 | 2016 | 631 | 0.13 | Why? |
| Primary Prevention | 1 | 2021 | 778 | 0.13 | Why? |
| Smallpox | 1 | 2014 | 96 | 0.13 | Why? |
| User-Computer Interface | 1 | 2020 | 1068 | 0.13 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2018 | 433 | 0.12 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2016 | 782 | 0.12 | Why? |
| Models, Biological | 3 | 2018 | 4907 | 0.12 | Why? |
| Basic Reproduction Number | 2 | 2021 | 2676 | 0.12 | Why? |
| Ships | 1 | 2020 | 1046 | 0.12 | Why? |
| Disease Transmission, Infectious | 3 | 2021 | 9044 | 0.11 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.11 | Why? |
| Spatio-Temporal Analysis | 1 | 2017 | 1182 | 0.10 | Why? |
| Bayes Theorem | 2 | 2017 | 3237 | 0.10 | Why? |
| Public Health Practice | 1 | 2018 | 945 | 0.10 | Why? |
| Contact Tracing | 2 | 2020 | 8448 | 0.10 | Why? |
| Demography | 1 | 2017 | 1660 | 0.10 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.09 | Why? |
| Cross Infection | 2 | 2021 | 8675 | 0.09 | Why? |
| Cystic Fibrosis | 1 | 2018 | 1104 | 0.09 | Why? |
| Epidemiological Monitoring | 2 | 2018 | 3493 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.09 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.08 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.08 | Why? |
| Humans | 31 | 2021 | 930598 | 0.08 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.08 | Why? |
| Sudan | 2 | 2018 | 166 | 0.08 | Why? |
| Forecasting | 2 | 2021 | 4492 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.07 | Why? |
| Peru | 2 | 2020 | 1010 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2018 | 1920 | 0.07 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.07 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.07 | Why? |
| Serologic Tests | 1 | 2018 | 4359 | 0.07 | Why? |
| Uganda | 2 | 2018 | 1057 | 0.06 | Why? |
| Health Behavior | 1 | 2021 | 4449 | 0.06 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.06 | Why? |
| Europe | 4 | 2021 | 12702 | 0.06 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.06 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.06 | Why? |
| Prevalence | 2 | 2021 | 25773 | 0.06 | Why? |
| Vaccines | 1 | 2020 | 3692 | 0.05 | Why? |
| Africa | 2 | 2020 | 2986 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2016 | 11304 | 0.05 | Why? |
| Biological Science Disciplines | 1 | 2020 | 72 | 0.05 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.05 | Why? |
| Calibration | 1 | 2020 | 307 | 0.05 | Why? |
| Reward | 1 | 2020 | 146 | 0.05 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.05 | Why? |
| Fiji | 1 | 2018 | 31 | 0.05 | Why? |
| Child | 4 | 2021 | 70012 | 0.05 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.04 | Why? |
| Seasons | 2 | 2021 | 4071 | 0.04 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.04 | Why? |
| World Health Organization | 2 | 2021 | 4213 | 0.04 | Why? |
| Sierra Leone | 1 | 2016 | 267 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Measles Vaccine | 1 | 2019 | 301 | 0.04 | Why? |
| Ohio | 1 | 2018 | 639 | 0.04 | Why? |
| Africa, Western | 1 | 2017 | 363 | 0.04 | Why? |
| Access to Information | 1 | 2020 | 483 | 0.04 | Why? |
| Likelihood Functions | 1 | 2018 | 719 | 0.04 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.03 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Poland | 1 | 2021 | 2368 | 0.03 | Why? |
| Immunization Schedule | 1 | 2020 | 1305 | 0.03 | Why? |
| Asia | 1 | 2020 | 2399 | 0.03 | Why? |
| Democratic Republic of the Congo | 1 | 2014 | 500 | 0.03 | Why? |
| Stochastic Processes | 1 | 2014 | 369 | 0.03 | Why? |
| Latin America | 1 | 2018 | 1721 | 0.03 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2014 | 8843 | 0.03 | Why? |
| Disease Notification | 1 | 2017 | 639 | 0.03 | Why? |
| United Kingdom | 2 | 2021 | 18046 | 0.03 | Why? |
| Neglected Diseases | 1 | 2015 | 381 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Publishing | 1 | 2020 | 990 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.03 | Why? |
| North America | 1 | 2014 | 1400 | 0.02 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.02 | Why? |
| Clinical Protocols | 1 | 2021 | 2734 | 0.02 | Why? |
| Middle East | 1 | 2014 | 1418 | 0.02 | Why? |
| Software | 1 | 2020 | 2501 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Immunization Programs | 1 | 2020 | 2006 | 0.02 | Why? |
| Germany | 1 | 2021 | 9196 | 0.02 | Why? |
| Zika Virus | 1 | 2018 | 1924 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2018 | 51949 | 0.02 | Why? |
| International Cooperation | 1 | 2019 | 3436 | 0.02 | Why? |
| Developing Countries | 1 | 2021 | 4283 | 0.02 | Why? |
| Computational Biology | 1 | 2020 | 4514 | 0.02 | Why? |
| Universities | 1 | 2020 | 4374 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.02 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.02 | Why? |
| Aged | 4 | 2021 | 215776 | 0.01 | Why? |
| Internet | 1 | 2020 | 6204 | 0.01 | Why? |
| Male | 5 | 2021 | 367725 | 0.01 | Why? |
| Female | 5 | 2021 | 380317 | 0.01 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
| Health Policy | 1 | 2021 | 6242 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2018 | 6817 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Adult | 3 | 2021 | 244371 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| United States | 1 | 2021 | 46150 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Time Factors | 1 | 2015 | 31397 | 0.01 | Why? |
| Lung | 1 | 2018 | 31049 | 0.01 | Why? |
| Vaccination | 1 | 2014 | 19050 | 0.01 | Why? |
Funk's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(222)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_